Clonidine in essential tremor: preliminary observations from an open trial
โ Scribed by M. R. Caccia; A. Mangoni
- Publisher
- Springer
- Year
- 1985
- Tongue
- English
- Weight
- 240 KB
- Volume
- 232
- Category
- Article
- ISSN
- 0340-5354
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
The objective of this study was to assess the tolerability and efficacy of rivastigmine in a group of patients with probable dementia with Lewy bodies (DLB), using an open label study. Open label treatment was with rivastigmine up to maximum tolerated dose (mean 9.6 mg daily, range 3-12 mg). Eleven
## Abstract This open study assessed the ability of rivastigmine to treat the neuropsychiatric complications of advanced Parkinson's disease. In a group of 12 patients, hallucinations, sleep disturbance, and carer distress were all improved and cognitive performance significantly enhanced by the dr